Overview

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

Status:
Completed
Trial end date:
2017-07-10
Target enrollment:
Participant gender:
Summary
Prospective, single-arm, longitudinal, international, multicenter study in a real-world cohort of adult severe asthma participants being conducted to assess the relationships between asthma biomarkers and asthma-related health-outcomes for a period of 52 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Theophylline